tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

URGN Stock Latest News

UroGen Pharma ‘commends’ BCAN release of Bladder Cancer Report
The FlyUroGen Pharma ‘commends’ BCAN release of Bladder Cancer Report
10d ago
URGN
Building Momentum With Zusduri: Strong Early Commercial Traction, Expanding Physician Adoption, and Pipeline-Funded Upside Support a Buy Rating
PremiumRatings
Building Momentum With Zusduri: Strong Early Commercial Traction, Expanding Physician Adoption, and Pipeline-Funded Upside Support a Buy Rating
14d ago
URGN
UroGen Pharma Earnings Call: Launch Momentum Meets Rising Costs
PremiumCompany Announcements
UroGen Pharma Earnings Call: Launch Momentum Meets Rising Costs
15d ago
URGN
UroGen Pharma: ZUSDURI Launch Momentum, Strengthening Balance Sheet, and Path to Profitability Support Buy Rating
PremiumRatings
UroGen Pharma: ZUSDURI Launch Momentum, Strengthening Balance Sheet, and Path to Profitability Support Buy Rating
20d ago
URGN
Trade Tensions Put UroGen Pharma’s Margins, Pipeline and Growth at Risk
PremiumCompany Announcements
Trade Tensions Put UroGen Pharma’s Margins, Pipeline and Growth at Risk
20d ago
URGN
UroGen Pharma Secures New $250 Million Term Loan
PremiumCompany AnnouncementsUroGen Pharma Secures New $250 Million Term Loan
21d ago
8K
URGN
UroGen Pharma reports Q4 EPS (54c), consensus (51c)
Premium
The Fly
UroGen Pharma reports Q4 EPS (54c), consensus (51c)
21d ago
URGN
UroGen Pharma sees FY26 net sales for Jelmyto $97M-$101M
Premium
The Fly
UroGen Pharma sees FY26 net sales for Jelmyto $97M-$101M
21d ago
URGN
UroGen Pharma announces refinanced term loan agreement with Pharmakon
PremiumThe Fly
UroGen Pharma announces refinanced term loan agreement with Pharmakon
21d ago
URGN
URGN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
URGN Upcoming Earnings Report: What to Expect?
23d ago
URGN
UroGen Pharma announces post-hoc analyses from Phase 3 trial of Zusduri
PremiumThe Fly
UroGen Pharma announces post-hoc analyses from Phase 3 trial of Zusduri
24d ago
URGN
UroGen’s Phase 1 UGN-301 Bladder Cancer Trial Completion: What Investors Should Watch Next
PremiumCompany Announcements
UroGen’s Phase 1 UGN-301 Bladder Cancer Trial Completion: What Investors Should Watch Next
2M ago
URGN
UroGen Pharma says permanent J Code for ZUSDURI now in effect
PremiumThe FlyUroGen Pharma says permanent J Code for ZUSDURI now in effect
3M ago
URGN
UroGen Pharma announces inducement grants under Nasdaq listing rule
Premium
The Fly
UroGen Pharma announces inducement grants under Nasdaq listing rule
4M ago
URGN
UroGen Pharma’s Promising Outlook: Buy Rating Backed by ZUSDURI’s Growth and Strong Financial Health
Premium
Ratings
UroGen Pharma’s Promising Outlook: Buy Rating Backed by ZUSDURI’s Growth and Strong Financial Health
4M ago
URGN
UroGen Pharma’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
UroGen Pharma’s Earnings Call: Growth Amid Challenges
5M ago
URGN
UroGen Pharma’s ZUSDURI Launch Drives Q3 Growth
PremiumCompany Announcements
UroGen Pharma’s ZUSDURI Launch Drives Q3 Growth
5M ago
URGN
UroGen Pharma files automatic mixed securities shelf
PremiumThe Fly
UroGen Pharma files automatic mixed securities shelf
5M ago
URGN
Urogen Pharma’s Promising Growth and Demand Surge Support Buy Rating
PremiumRatings
Urogen Pharma’s Promising Growth and Demand Surge Support Buy Rating
5M ago
URGN
UroGen Pharma reports Q3 EPS (69c), consensus (68c)
PremiumThe FlyUroGen Pharma reports Q3 EPS (69c), consensus (68c)
5M ago
URGN
UroGen Pharma announces preliminary results from Phase 3 UTOPIA trial
Premium
The Fly
UroGen Pharma announces preliminary results from Phase 3 UTOPIA trial
5M ago
URGN
UroGen Pharma’s UGN-104 Study: A Potential Game-Changer in Urothelial Cancer Treatment
Premium
Company Announcements
UroGen Pharma’s UGN-104 Study: A Potential Game-Changer in Urothelial Cancer Treatment
5M ago
URGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >